Venus Medtech (Hangzhou) Inc. (2500.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Venus Medtech (Hangzhou) Inc., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -2.30x |
| P/B Ratio | 0.53x |
| P/S Ratio | 3.05x |
| Profitability | |
| Gross Margin | 69.0% |
| Operating Margin | -112.6% |
| Net Margin | -132.9% |
| EBITDA Margin | -102.8% |
| Liquidity | |
| Current Ratio | 2.77x |
| Quick Ratio | 2.37x |
| Leverage | |
| Debt/Equity | 0.12x |
YoY = year-over-year change. Source: FMP..